135 related articles for article (PubMed ID: 10207908)
1. Connexins in tumour suppression and cancer therapy.
Yamasaki H; Omori Y; Krutovskikh V; Zhu W; Mironov N; Yamakage K; Mesnil M
Novartis Found Symp; 1999; 219():241-54; discussion 254-60. PubMed ID: 10207908
[TBL] [Abstract][Full Text] [Related]
2. Role of connexin (gap junction) genes in cell growth control and carcinogenesis.
Yamasaki H; Krutovskikh V; Mesnil M; Tanaka T; Zaidan-Dagli ML; Omori Y
C R Acad Sci III; 1999; 322(2-3):151-9. PubMed ID: 10196667
[TBL] [Abstract][Full Text] [Related]
3. Gap junction proteins connexin32 and connexin43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails.
Omori Y; Yamasaki H
Carcinogenesis; 1999 Oct; 20(10):1913-8. PubMed ID: 10506104
[TBL] [Abstract][Full Text] [Related]
4. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.
Mesnil M; Piccoli C; Tiraby G; Willecke K; Yamasaki H
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1831-5. PubMed ID: 8700844
[TBL] [Abstract][Full Text] [Related]
5. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells.
Elfgang C; Eckert R; Lichtenberg-Fraté H; Butterweck A; Traub O; Klein RA; Hülser DF; Willecke K
J Cell Biol; 1995 May; 129(3):805-17. PubMed ID: 7537274
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes.
Duflot-Dancer A; Mesnil M; Yamasaki H
Oncogene; 1997 Oct; 15(18):2151-8. PubMed ID: 9393973
[TBL] [Abstract][Full Text] [Related]
7. Involvement of gap junctions in tumor suppression: analysis of genetically-manipulated mice.
Omori Y; Zaidan Dagli ML; Yamakage K; Yamasaki H
Mutat Res; 2001 Jun; 477(1-2):191-6. PubMed ID: 11376700
[TBL] [Abstract][Full Text] [Related]
8. Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects.
Nicholas TW; Read SB; Burrows FJ; Kruse CA
Histol Histopathol; 2003 Apr; 18(2):495-507. PubMed ID: 12647801
[TBL] [Abstract][Full Text] [Related]
9. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours.
Jamieson S; Going JJ; D'Arcy R; George WD
J Pathol; 1998 Jan; 184(1):37-43. PubMed ID: 9582525
[TBL] [Abstract][Full Text] [Related]
10. Role of connexin (gap junction) genes in cell growth control: approach with site-directed mutagenesis and dominant-negative effects.
Omori Y; Duflot-Dancer A; Mesnil M; Yamasaki H
Toxicol Lett; 1998 Aug; 96-97():105-10. PubMed ID: 9820654
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis.
Yamasaki H; Omori Y; Zaidan-Dagli ML; Mironov N; Mesnil M; Krutovskikh V
Cancer Detect Prev; 1999; 23(4):273-9. PubMed ID: 10403898
[TBL] [Abstract][Full Text] [Related]
12. Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice.
Nagy JI; Ionescu AV; Lynn BD; Rash JE
Glia; 2003 Dec; 44(3):205-18. PubMed ID: 14603462
[TBL] [Abstract][Full Text] [Related]
13. Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: implications for gene therapy.
Carrió M; Mazo A; López-Iglesias C; Estivill X; Fillat C
Int J Cancer; 2001 Oct; 94(1):81-8. PubMed ID: 11668482
[TBL] [Abstract][Full Text] [Related]
14. Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapy.
Jimenez T; Fox WP; Naus CC; Galipeau J; Belliveau DJ
Cell Commun Adhes; 2006; 13(1-2):79-92. PubMed ID: 16613782
[TBL] [Abstract][Full Text] [Related]
15. A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells.
Mesnil M; Piccoli C; Yamasaki H
Cancer Res; 1997 Jul; 57(14):2929-32. PubMed ID: 9230203
[TBL] [Abstract][Full Text] [Related]
16. Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes.
Tanaka T; Yamasaki H; Mesnil M
Mol Carcinog; 2001 Mar; 30(3):176-80. PubMed ID: 11301478
[TBL] [Abstract][Full Text] [Related]
17. Gap junctions: the "kiss of death" and the "kiss of life".
Andrade-Rozental AF; Rozental R; Hopperstad MG; Wu JK; Vrionis FD; Spray DC
Brain Res Brain Res Rev; 2000 Apr; 32(1):308-15. PubMed ID: 10751679
[TBL] [Abstract][Full Text] [Related]
18. Gap junctional connexin messenger RNA expression in the ovine uterus and placenta: effects of estradiol-17β-treatment, early pregnancy stages, and embryo origin.
Johnson ML; Redmer DA; Reynolds LP; Grazul-Bilska AT
Domest Anim Endocrinol; 2017 Jan; 58():104-112. PubMed ID: 27835804
[TBL] [Abstract][Full Text] [Related]
19. Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication.
Xiao J; Zhang G; Li B; Wu Y; Liu X; Tan Y; Du B
Oncotarget; 2017 Jan; 8(1):798-807. PubMed ID: 27903977
[TBL] [Abstract][Full Text] [Related]
20. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy.
Estin D; Li M; Spray D; Wu JK
Neurosurgery; 1999 Feb; 44(2):361-8; discussion 368-9. PubMed ID: 9932890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
